The Society of Chemical Manufacturers & Affiliates (SOCMA) recently announced that Jenn Klein has been selected as the organization's next President & Chief Executive Officer after a national search.
A.N. Sreeram, Senior VP and Chief Technology Officer, will retire from Dow at the end of June. Andre Argenton will move to the newly created role of Chief Technology & Sustainability Officer.
Seasoned Syensqo business leader to guide the company’s next chapter.
Women In Chemicals announced that Amber Thichangthong will step down as Executive Director at the end of 2025 and will be succeeded by experienced nonprofit leader Katie Hess effective January 1, 2026.
Markus Kamieth, CEO of BASF, has been appointed the new President of the European Chemical Industry Council CEFIC, effective January 1, 2026.
As of January 1, 2026, Christoph Garbotz will be Managing Director for IMCD Germany.
Emmanuel Colette will assume global leadership of IMCD's Food & Nutrition business group with effect from 1 March 2026.
Bachem's Board of Directors has appointed Anne-Kathrin Stoller, the former Head of Bachem Americas and previously the company's CMO for many years, as the new CEO effective January 1, 2026.
Sterling Pharma Solutions announced the appointment of Karl Rotthier as Chief Executive Officer (CEO), effective 21 October, 2025.
Syensqo has announced that Ilham Kadri will step down as CEO on January 1, 2026, with Mike Radossich, current President of Performance & Care, set to assume the role and lead the company into its next growth phase.
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
Kai Beckmann to succeed Belén Garijo as new Chairman of the Executive Board and CEO of Merck in May 2026.
The Supervisory Board of Tesa has appointed Kourosh Bahrami as the new CEO. He will take over the position on October 1, 2025 from Norman Goldberg, who is leaving the company at his own request.
Lars Wallstein was re-elected as the European Association of Chemical Distributors (FECC) President. The new board takes office at the 2025 general assembly.
Shrieve Chemical Company has appointed Joey Gullion, an industry veteran with over 25 years of commercial leadership experience, as its new Chief Executive Officer.
Hans Van Hees will join Bachem's Corporate Executive Committee as global Chief Operations Officer (COO) on September 1, 2025.
Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova, Quotient Sciences' CRDMO.
After nearly nine years of dedicated leadership, SOCMA President & CEO Jennifer Abril has stepped down. Vera Stoeva will serve as interim President & CEO, ensuring a smooth transition and steady leadership.
Heino Lennartz will take over the role on an interim basis until Verheyden takes office in fall 2025.
Abzena, an end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, recently announced that Geoffrey M. Glass has been appointed Chief Executive Officer, effective immediately.
German oxo-chemicals manufacturer Oxea has appointed Michael McHenry as its new CEO with effect from August 15, 2025.
The pharmaceutical service provider Siegfried has announced changes to its management team. Marianne Späne, who has been with the Swiss CDMO since 2004 and has held the position of Chief Business Officer since the beginning of 2020, is moving to the Board of Directors of the subsidiary Dinamiqs.
Bayer's Supervisory Board has unanimously decided to extend the contract with the company's CEO, Bill Anderson, until March 31, 2029.
Thorsten Dreier will remain Covestro's Chief Technology Officer for another five years. The Supervisory Board has extended his contract until June 30, 2031.
IMCD recently appointed Andreas Igerl as Regional President EMEA and as Leader of the global Industrial Business Groups, and Narendra Varde as Regional President APAC.
Roquette Appoints Thierry Fournier as Chief Executive Officer
Veranova appoints Matteo Villain as Vice President of Peptides and Oligonucleotides, strengthening its position as a key player in the Peptide and Oligonucleotide (TIDES) space.
CMO Symbiosis has appointed Angelika Rublack as Senior Business Development Manager to support its expanding global client base and drive growth across several territories.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Bristol Myers Squibb appoints Cari Gallman as EVP and invests $40 billion in the US over 5 years.
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, to succeed Richard Packer as Head of Healthcare.
CDMO Suanfarma appoints Pere Mañé Godina as its new CEO, marking the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.
Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the Board of Managing Directors.
